Alignment Healthcare (NASDAQ:ALHC) President Sells $482,700.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $16.09, for a total transaction of $482,700.00. Following the sale, the president directly owned 998,813 shares in the company, valued at $16,070,901.17. This trade represents a 2.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.87, for a total transaction of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16.
• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.48, for a total transaction of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.45, for a total transaction of $508,021.85.

Alignment Healthcare Stock Performance

Shares of ALHC stock traded up $0.08 during trading hours on Tuesday, reaching $16.36. The stock had a trading volume of 3,766,382 shares, compared to its average volume of 3,860,182. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The firm has a 50-day simple moving average of $18.98 and a 200-day simple moving average of $19.45. The firm has a market capitalization of $3.38 billion, a PE ratio of 181.78, a price-to-earnings-growth ratio of 2.20 and a beta of 1.26.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter last year, the company earned ($0.05) EPS. The company’s revenue for the quarter was up 33.3% compared to the same quarter last year. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current year.

Wall Street Analyst Weigh In

ALHC has been the topic of a number of analyst reports. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a report on Thursday, May 7th. Wolfe Research initiated coverage on shares of Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price objective on the stock. UBS Group increased their price objective on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. KeyCorp reiterated an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Finally, Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $24.60.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of ALHC. Summit Securities Group LLC bought a new position in Alignment Healthcare in the 4th quarter valued at about $26,000. Parallel Advisors LLC grew its position in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after buying an additional 773 shares in the last quarter. Larson Financial Group LLC bought a new position in Alignment Healthcare in the 3rd quarter valued at about $33,000. First Horizon Corp bought a new position in Alignment Healthcare in the 4th quarter valued at about $39,000. Finally, GAMMA Investing LLC grew its position in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.